Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

RoosterBio Blog

RoosterPubs in 2024 & Beyond: Catalyzing Bio-Research to “Publish & Flex”

January 30, 2025 Corporate

Above, a word cloud generated by ChatGPT 4o (openai.com) using input from RoosterBio-attributing publications’ abstracts and titles from 2024. For those with limited experience in this arena, it might be ... More

Winners of RoosterBio’s 2024 Development Award

January 07, 2025 Corporate

Mesenchymal stem cells (MSCs) and their derivatives are a critical raw material for a growing number of emerging advanced therapeutic applications, including engineered cell and gene therapies, engineered tissues, combination ... More

Sidebar Navigation

  • BioEconomy
  • Biomanufacturing
  • Bioprinting & Biofabrication
  • Bioprocessing
  • Cell Therapy
  • Conference Highlights
  • Corporate
  • COVID-19
  • Exosomes / Extracellular Vesicles
  • Genetic Engineering
  • MSCs & Characterization
  • Quality & Regulatory
  • Tissue Engineering
#1 Most Popular Blogs 3D Culture Adipose MSCs Adult Stem Cells Advanced Therapies Analytics BioEconomy Biomanufacturing Biomaterials Bioprinting / Biofabrication Bioprocess Bioreactors Bone Marrow MSCs Cell Therapy Clinical Trials COVID-19 Democratizing Technology Exosomes / Extracellular Vesicles Fetal Bovine Serum Genetic Engineering GMP Manufacturing Mesenchymal Stem / Stromal Cells Regenerative Medicine Regulatory RoosterBio Standardization Tissue Engineering Umbilical Cord MSCs

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email